Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity

Citation
Dj. Marciani et al., Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity, VACCINE, 18(27), 2000, pp. 3141-3151
Citations number
41
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
18
Issue
27
Year of publication
2000
Pages
3141 - 3151
Database
ISI
SICI code
0264-410X(20000715)18:27<3141:DOSTSD>2.0.ZU;2-0
Abstract
Aldehyde-containing triterpene saponins have adjuvant properties, but only those from Quillaja saponaria Molina stimulate the production of cytotoxic T lymphocytes (CTL) against exogenous antigens. Quillaja saponins have two normonoterpene ester moieties, linked linearly to their fucosyl residue, th at play a critical role in the stimulation of CTL. These ester moieties are also responsible for these saponins' instability and toxicity. Based on th e structure-activity relationships for the different groups of Q. saponaria saponins, new semi-synthetic analogs were developed that have the adjuvant icity of quillaja saponins, yet with less toxicity and greater stability in aqueous solutions. The quillaja saponin analogs were prepared by replacing their hydrolytically unstable ester groups with another lipophilic chain l inked by a stable amide bond on these saponins' glucuronic acid residue. On e of these analogs, GPI-0100, is a dodecylamide saponin derivative that sti mulates an antibody isotype profile that corresponds to a Th1 type immune r esponse, as well as CTL production against exogenous antigens. (C) 2000 Els evier Science Ltd. All rights reserved.